Publication date context February 19 2026 informs readers that a ClinicalTrials.gov record NCT07414069 is advancing in the area of carpal tunnel syndrome. The sponsor Ankara City Hospital Bilkent lists recruitment as ongoing and intends to compare High intensity Laser Therapy with a sham laser therapy device. The study title signals it will assess clinical sonographic and electrophysiological outcomes, a framework consistent with regulatory expectations for device evaluation. This article summarizes what the trial means for patients clinicians and device developers under MDR requirements and highlights what stakeholders should watch as the registry evolves.
What is this trial about?
The carpal tunnel syndrome study evaluates a device described as High intensity Laser Therapy and its sham counterpart in a controlled setting. The registry title points to clinical, sonographic and electrophysiological outcomes as the focus of assessment. The sponsor Ankara City Hospital Bilkent confirms recruitment and indicates the trial will be conducted in a real world clinical context under an approved protocol. No results are yet reported in the source text and the registry entry should be consulted for current status and updates.
What condition is carpal tunnel syndrome?
Carpal tunnel syndrome is a compressive nerve disorder of the wrist that can cause pain numbness and functional impairment. The trial targets patients with this condition and uses a laser device as therapy and a sham device as control to enable a blinded evaluation of potential effects on clinical symptoms and nerve function.
Who is conducting the trial and how is it designed?
The trial is sponsored by Ankara City Hospital Bilkent and is described as recruiting. The intervention is High intensity Laser Therapy and the comparator is a sham High intensity Laser Therapy device. The use of a sham control supports unbiased assessment of any treatment effect and aligns with common regulatory expectations for device trials. The source text does not provide details on randomization blinding or sample size but these items are typically declared in the full registry entry.
What is the study design?
The source text implies a parallel group design with a sham comparator. The public registry format supports transparency for clinicians patients regulators and potential manufacturers seeking to understand how the device would be evaluated in a clinical setting.
What outcomes are being measured?
The study title indicates outcomes include clinical measures as well as sonographic and electrophysiological endpoints. Specific instruments time points and analysis plans are not provided in the source text. Practitioners and developers will look for standardized symptom scores functional assessments and objective nerve function data to gauge feasibility and potential benefit of the therapy.
What regulatory implications could emerge?
From a regulatory viewpoint the trial aligns with MDR Annex XIV that governs the lifecycle of medical devices including proof of intended purpose performance and safety. The therapy is described as a laser device for a musculoskeletal condition and the trial uses a sham comparator as part of the evaluation. Depending on results and quality of reporting this study could inform future regulatory submissions including device labeling and potential post market considerations. Sponsors investigators and site staff should maintain compliant reporting in line with good clinical practice and registry standards.
What is the timeline and next steps?
Current status shows recruiting activity and the timeline will depend on enrollment speed and follow up assessments. Stakeholders should monitor registry updates for new information on outcomes or design amendments. When results become available they may influence subsequent regulatory submissions or labeling decisions based on the consistency and strength of evidence across measured endpoints.
FAQ
- 1. What device is studied in this trial The intervention is High intensity Laser Therapy and a sham High intensity Laser Therapy device.
- 2. What condition is being studied Carpal tunnel syndrome.
- 3. Who is sponsoring the trial Ankara City Hospital Bilkent.
- 4. Where can I find the trial record On ClinicalTrials.gov at NCT07414069 with the term medical device.
Conclusion and implications
The trial represents a structured approach to generate robust data on a device therapy for carpal tunnel syndrome. If outcomes show benefits that are confirmed through independent review regulatory pathways may consider new evidence for device labeling and use. For device developers the study demonstrates the value of sham controlled designs in establishing credible evidence for regulatory submissions. Clinicians and patients should stay alert to registry updates and consult official regulatory guidance for MDR compliance and device safety.
Disclaimer This article is for professional informational purposes only and is not legal advice Regulatory requirements vary by jurisdiction and may change Consult qualified counsel and official regulatory resources for current rules and submissions.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07414069?term=medical+device